Publications by authors named "Ines Valencia"

Claim this Profile
P
Pharmacological evaluation of non-nucleotide purine derivatives as P2X7 antagonists for the treatment of neuroinflammation in traumatic brain injury.
Inés Valencia, Andrea Pastor-Martínez, Céline Decouty-Pérez, Ana Belen Lopez-Rodriguez, María Álvarez-Rubal

Br J Pharmacol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 S Protein Reduces Cytoprotective Defenses and Promotes Human Endothelial Cell Senescence.
Alicia Villacampa, Licia Shamoon, Inés Valencia, Cristina Morales, Sofía Figueiras

Aging Dis· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus.
Inés Valencia, Jairo Lumpuy-Castillo, Giselle Magalhaes, Carlos F Sánchez-Ferrer, Óscar Lorenzo

Cardiovasc Diabetol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Redox Regulation of Microglial Inflammatory Response: Fine Control of NLRP3 Inflammasome through Nrf2 and NOX4.
Alejandra Palomino-Antolín, Céline Decouty-Pérez, Víctor Farré-Alins, Paloma Narros-Fernández, Ana Belen Lopez-Rodriguez, Inés Valencia

Antioxidants (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DPP4 Promotes Human Endothelial Cell Senescence and Dysfunction via the PAR2-COX-2-TP Axis and NLRP3 Inflammasome Activation.
Inés Valencia, Susana Vallejo, Pilar Dongil, Alejandra Romero, Álvaro San Hipólito-Luengo

Hypertension· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resolvin E1 attenuates doxorubicin-induced endothelial senescence by modulating NLRP3 inflammasome activation.
Licia Shamoon, Jenaro A Espitia-Corredor, Pilar Dongil, Marta Menéndez-Ribes, Alejandra Romero, Inés Valencia

Biochem Pharmacol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological Blockade of NLRP3 Inflammasome/IL-1β-Positive Loop Mitigates Endothelial Cell Senescence and Dysfunction.
Alejandra Romero, Pilar Dongil, Inés Valencia, Susana Vallejo, Álvaro San Hipólito-Luengo

Aging Dis· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NLRP3 Inflammasome in Vascular Disease: A Recurrent Villain to Combat Pharmacologically.
Ainara González-Moro, Inés Valencia, Licia Shamoon, Carlos Félix Sánchez-Ferrer, Concepción Peiró

Antioxidants (Basel)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
Inés Valencia, Concepción Peiró, Óscar Lorenzo, Carlos F Sánchez-Ferrer, Jürgen Eckel

Front Pharmacol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visfatin/eNampt induces endothelial dysfunction in vivo: a role for Toll-Like Receptor 4 and NLRP3 inflammasome.
Tania Romacho, Inés Valencia, Mariella Ramos-González, Susana Vallejo, Miguel López-Esteban

Sci Rep· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The angiotensin-(1-7)/Mas receptor axis protects from endothelial cell senescence via klotho and Nrf2 activation.
Alejandra Romero, Álvaro San Hipólito-Luengo, Laura A Villalobos, Susana Vallejo, Inés Valencia

Aging Cell· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis